Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.

Haematologica

Volumn 88, Issue 4, 2003, Pages

  Visani, Giuseppe ^a   Piccaluga, Pier Paolo ^a   Martinelli, Giovanni ^a   Rossi, Maura ^a   Malagola, Michele ^a   Baccarani, Michele ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; ORGANOARSENIC DERIVATIVE; OXIDE; RETINOIC ACID;

CASE REPORT; DRUG POTENTIATION; HUMAN; LETTER; MALE; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PROMYELOCYTIC LEUKEMIA; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; DRUG SYNERGISM; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; OXIDES; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN;

EID: 4544275440     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)